Products

Conveniently located to serve the areas of Maryland, Virginia and Washington, D.C.

Latisse

What Is Latisse?

LatisseAfter a successful clinical trial in 2008, the Food and Drug Administration (FDA) approved the prescription medication bimatoprost (brand name Latisse) to treat the condition of eyelash hypotrichosis (the medical term for inadequate eyelashes). With regular applications along the lash line of the upper eyelid, Latisse gradually encourages growth of longer, fuller, and darker eyelashes. Patients treated with Latisse in the clinical study experienced a 25% increase in lash length, 106% increase in lash thickness/fullness, and 18% increase in lash darkness.

At Cosmetic Surgery Associates, with offices in Mclean, VA, and Bethesda, MD, Dr. Dean Jabs, M.D., Dr. Franklin Richards, M.D., and Dr. Keshav Magge, M.D. have had excellent results when prescribing Latisse to their patients, and will provide you with clear and thorough instruction, to ensure that you achieve the best possible results when using Latisse.

The Latisse Procedure

Latisse is a prescription treatment applied to the base of your upper eyelid lash margin (Latisse is not meant to be applied to your lower eyelid). To achieve optimal results, Latisse should be used once a day for 16 weeks.  The eyelash thickening, darkening, and lengthening results of Latisse are gradual—you may start to notice longer lashes after one month, and you will see complete results in approximately four months. Applying Latisse more than once a day will not increase the efficacy of the product. If you discontinue using Latisse, your lashes will eventually return to their original appearance over the course of the next few months. Common side effects of Latisse are itchy and red eyes, and, although very infrequent, Latisse may cause a permanent increase in the brown pigmentation of the colored part of the eye.

Zo® Skin Health

ZO Skin Health Type Only-Black

Click here to buy Zo® Skin Health Products

Click here to buy ZO Skin Health Products

MD Frames-Group